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SUMMARY
In 30 ambulatory patients (14 men and 16 women), with diabetes mellitus (7 of type I and 23
of type II) of variable duration and with ages averaging 52.2 years, the degree of retinal microan
giopathy was assessed along with the erythrocyte filtration rate (FR) and the percentage of
glycosylated hemoglobin (HbA,).
The FR was significantly (p < 0.001) lower among the diabetics (12.09 ± 2.71 JAI sec-I) than in
the controls (15.80 ± 1.75). On the other hand, the level of HbA1 was significantly (p < 0.001)
higher in the diabetics (12.26 ± 3.83) than in the control group (7.97 ± 1.47). The severity of the
diabetic retinopathy was estimated as follows: degree Tin 10 patients, degree II in 10 patients al
so, degree III in 4 patients and no abnormalities in 6 individuals.
Among the patients the retinal lesions were significantly correlated (r = -0.46, p < 0.01) with
the value of FR but were not affected by the level of HbA,. No significant correlation was detec
ted between FR and HbA,.
Our results suggest that, as a consequence of the metabolic abnormalities present in the diabe
tics, the non-enzymatic glycosylation of hemoglobin A is increased.
The rise of erythrocyte rigidity, while hampering blood-flow through already injured micro-
vessels, could contribute to the development of retinal abnormalities irrespective of the HbA, le
vel. Consequently, the abnormalities in the retinal microcirculation could, directly or indirectly,
influence red cell filtrability, worsening the rheologic behaviour in the local microvessels.
INTRODUCTION
Macro- and microvascular abnormalities are fre
quently reported in association to diabetes.”2 The re
tinopathy is part of the systemic microangiopathy and
is frequently observed in long-established diabetes.2’3
Apparently, the retinal lesions observed in diabetes
stand for similar abnormalities in other tissues.
Among other important factors, the development of
the microangiopathy seems to depend on the date of
onset of the disease and the degree of metabolic con
trol.2
Several rheologic abnormalities have been detec
ted in diabetes. Former works suggest that these he
morheologic disturbances contribute to the develop
ment and/or progress of diabetic vasculopathy.4-6
This work was ment to study the relationship bet
ween the changes of erythrocyte filtrability and the
presence of retinal microangiopathy in a group of
adult diabetic patients either insulin-dependent or
not.
MATERIAL AND METHODS
Thirty ambulatory diabetic patients and 34
healthy controls consented to take part in this study.
The group of diabetics, made up by 14 men and 16
women with 52.2 years of average age and whose di
sease already coursed for a variable time had no ke
toacidosis or other pathologic complications. The
control group included 16 men and 18 women of com
parable age (average 54.6 years) without family his
tory of diabetes, retinal vascular pathology or excessi
ve weight.
Besides the physical examination, ECG and routi
ne hematologic and biochemical analysis, in all the in
dividuals (diabetic patients and controls) signs of reti
nal microangiopathy were searched for.
Based on the separate observations of two oph
thalmologists a protocol was worked up including the
assessment of all visual functions and eye structures
taking particular notice of the ocular fundi (reflec
tion, biomicroscopy, tonometry and funduscopy).
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TABLE 1 — Values (mean ± standard deviation) of plasma glucose, total
glycosylated hemoglobin (HbA,) and red cell filtration rate (FR) in 30 diabe
tics and 34 normal controls.
Glucose HbA, FRGroups (mmol/1) (%) JA1. seg-’
Diabetics 11.82 ± 3.48 12.26 ± 3.83 12.09 ± 2.71
p values < 0.001 < 0.00 1 < 0.00 1
Controls 3.88 ± 0.67 7.97 ± 1.47 15.80 ± 1.75
The study was completed with fluorescein angio
graphy (50 ml, 2OWo sodium fluorescein injected in
veins of the forearm) to assess the degree of microvas
cular involvement of the retina.
The diabetic patients were classified according to
the presence and extent of retinal abnormalities; viz:
Grade 0 — no retinopathy (total 6); grade I — back
ground retinopathy (total 10); grade II — retinopathy
showing signs of ischemia (total 10); grade III — pro
liferative retinopathy (total 4).
A fasting venous blood sample was collected from
each individual in order to assay plasma glucose (by
glucose-oxidase method, Kit n.° 510 Sigma),
glycosylated hemoglobin (HbA,)7 and red cell filtra
tion rate (FR, corrected by hematocrit).8
RESULTS AND DISCUSSION
The HbA, is considered to be a better marker of
the metabolic control of diabetes than the glucose
blood levels.9’ 1O~ As opposed to the daily fluctuations
of glycemia, the HbA,, values tend to suffer deep va
riations after a couple of weeks of therapy or follo
wing severe drawback in the clinical course of the di
sease.” 12 However, according to the values obtained
for both these parameters (Table I) in the present
work, the diabetic patients seemed to be in a rather
poor metabolic condition. The very significant rise of
HbA1 was clearly affeëted (r 0.43, p < 0.05) by si
multaneous fluctuations of glucose level. None of the
se parameters was either dependent on age or time of
onset of the disease nor did they interfere with the se
verity of retinal abnormalities (detected in 80% of the
patients), which is in accordance with the sluggishness
of evolution of diabetic microangiopathy.3 Retinal le
sions have been attributed, among other causes, to the
hypoxia associated to metabolic imbalance.2’ 13 Appa
rently, diabetes affects, by itself, the capacity of tissue
oxygenation, which would be related with the over
production of a hemoglobin fraction with an increa
sed oxygen affinity (HbA1).’4
Tissue oxygenation may, however, be affected by
other factors. Besides oxygen affinity of the hemoglo
bin, local changes of bloodilow may also significantly
contribute to the reduction of oxygen delivery to peri
pheral tissues, favouring the development of microan
giopathy of which retinal abnormalities are an outs
tanding component.’5’ 16 The well known microrheo
logic disorders found in diabetes,’~6’ ~6 particulary the
increased red cell rigidity (Table I), would contribute
to bloodflow stagnation and, accordingly, to local
hypoxia. The development of retinal lesions would
be, therefore, partly ascribed to episodes of hypoxia,
dependent on the rise of HbA1 and on the reduction
of red cell deformability. As opposed to the lack of
correlation between the severity of retinal abnormali
ties and the percentage of HbA1, the parallelism ob
served with filtration rate values (r —0.46,
p < 0.01) hints that diabetic microangiopathy is
affected by circulating red cells’ rigidity.
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